The detection device, BacterioScan 216DX, transmits a laser through urine samples to determine whether bacteria are multiplying. If it detects growing bacteria, a patient has an infection.
BacterioScan can reduce the average time it takes to make a UTI diagnosis from two days to three hours, according to Dana Marshall, president and CEO of the startup,
“In U.S. hospitals, maybe two-thirds of the samples that get processed are urine that’s tested for UTI,” Ms. Marshall told St. Louis Public Radio. “Of those, about 80 percent are negative. So this test is just a fast way to remove all those negative samples from the workflow so that the skilled people can focus on known positive samples and so patients who don’t have an infection can be taken off antibiotics.”
The device will first be used in hospital laboratories. The startup hopes to expand its use to physician’s offices and eventually harvest the technology to detect blood infections.
More articles on supply chain:
Vermont first state to legalize drug importation from Canada
6 key proposals unveiled in Trump’s plan to combat rising drug costs
62% of hospital leaders support Amazon as a medical supplier
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
